Sylvester cancer researcher and technology innovator named fellow of the
ScienMag,
MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive…
MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive…
MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive…
Inventions and innovations from the lab of Shanta Dhar, Ph.D., are helping to guide targeted therapies in cancer and other…
Newswise — MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester…
JULY 2023 TIP SHEET: A first-of-its kind drug for prostate cancer, an ancient retrovirus that may drive aggressive brain cancer…
Newswise — Sylvester Researchers Develop Oral Chemotherapy Drug for Treatment-Resistant Prostate Cancer Researchers at…
Post Views: 2 Sylvester Researchers Develop Oral Chemotherapy Drug for Treatment-Resistant Prostate Cancer Researchers at…
Medizin Freitag, 21. Juli 2023 Miami – In-vivo-Experimente am Tiermodell deuten darauf hin, dass Cisplatin-Resistenzen bei…
Prostate cancer is a leading cause of death among American men, and it’s resistant to one of the most powerful chemotherapy…
Kara Murez Health Day Reporter (Health Day) THURSDAY, July 13, 2023 (HealthDay News) — A preclinical study offers a potential…
Credit: ACS Central Science (2023). DOI: 10.1021/acscentsci.3c00286 Prostate cancer is a leading cause of death among American…
Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy…
A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the…
A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the…
The study used the chemotherapy drug cisplatin, administered orally, to disrupt the metabolism of prostate cancer cells and…
By Cara Murez HealthDay Reporter THURSDAY, July 13, 2023 -- A preclinical study offers a potential new therapy for treatment-resi…
THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study offers a potential new therapy for treatment-resistant prostate…
THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study offers a potential new therapy for treatment-resistant prostate…
THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study offers a potential new therapy for treatment-resistant prostate…
Cara Murez THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study offers a potential new therapy for treatment-resistant…
THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study offers a potential new therapy for treatment-resistant prostate…
New Type of Treatment Tackles Tough-to-Treat Prostate Cancer THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study…
By Cara Murez HealthDay Reporter THURSDAY, July 13, 2023 (HealthDay News) -- A preclinical study offers a potential new therapy…
Researchers atSylvester Comprehensive Cancer Centerat the University of Miami Miller School of Medicine have developed a first-of…
Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy…
Listen with Speechify Register for free to listen to this article Thank you. Listen to this article using the player above.
Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy…
A new drug could offer hope to patients with advanced prostate cancer. () A new pill for advanced has been developed by…
A new pill for advanced prostate cancer has been developed by scientists, giving hope to those living with the disease.
A new pill for advanced prostate cancer has been developed by scientists, giving hope to those living with the disease.
Newswise — Prostate cancer is a leading cause of death among American men, and it’s resistant to one of the most powerful…
Newswise — MIAMI, FLORIDA (EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET) – Researchers at Sylvester Comprehensive Cancer Center at…
Prostate cancer is a leading cause of death among American men, and it’s resistant to one of the most powerful chemotherapy…
MIAMI, FLORIDA (EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET) – Researchers at Sylvester Comprehensive Cancer Center at the…
MIAMI, FLORIDA (EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET) – Researchers at Sylvester Comprehensive Cancer Center at the…
MIAMI, FLORIDA (EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET) Researchers at Sylvester Comprehensive Cancer Center at the…
Prostate cancer is a leading cause of death among American men, and its resistant to one of the most powerful chemotherapy…
Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy…
Post Views: 1 Prostate cancer is a leading cause of death among American men, and its resistant to one of the most powerful…
Post Views: 27 MIAMI, FLORIDA (EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET) Researchers at Sylvester Comprehensive Cancer Center…